Navigation Links
OptumHealth Launched myOptumHealth.com, Health and Wellness Information Destination with Clinically Reviewed Content, Tools and Resources
Date:12/11/2008

Built upon its expertise in serving 60 million Americans, OptumHealth developed myOptumHealth.com to provide individuals seeking health and wellness information online with free access to clinically reviewed, easy-to-understand and actionable content, tools and resources.

Golden Valley, MN (PRWEB) December 11, 2008 -- OptumHealth Inc., the health and wellness business of UnitedHealth Group, announced the launch of myOptumHealth.com, a free consumer health and wellness Web site designed to assist the 76 million Internet consumers who look for health information online each month (1).

"Our content is medically reviewed and vetted by clinicians through a strict process that includes a third-party medical advisory board, and follows leading evidence-based medicine guidelines," said Dr. Janet Bruno, medical director for OptumHealth Consumer Solutions, which operates myOptumHealth.com. "These guidelines ensure the content is gathered with scientific methods and used judiciously to present only the best evidence to people who may be making important health care decisions."

Much of the myOptumHealth.com site features content that is produced by an editorial staff comprised of medical doctors, PhDs, registered dietitians and writers from a variety of well-respected health publications and Web sites. Topics focus on current health and wellness-oriented issues such as weight loss, nutrition, diabetes, parenting, women's health, men's health and seniors' health.

While myOptumHealth.com is a free, public Web site, it also serves as a template for private health portals and consumer tools, including wellness coaching programs and incentive and communications services. OptumHealth is the largest publisher of private health portals
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4 5

Related medicine news :

1. Providence Service Corporation and UnitedHealth Group Affiliate, OptumHealth Behavioral Solutions, Enter Into Strategic Relationship Agreement
2. OptumHealth Launches myOptumHealth.com, Consumer-Focused Health and Wellness Information Web Site
3. Internet TV Network for Personal Trainers is Launched
4. Inhalant Abuse Prevention Program to Be Launched in Maryland Schools
5. AZoOptics.com - The A to Z of Optics Launched By AZoNetwork
6. New Initiative Launched to Anticipate Future of AIDS
7. StopMusclePain.com Launched as Only Website Dedicated to Reversing Back Pain
8. Handbook of cancer prevention launched by ESMO
9. Eco Site Awards Launched to Honor Organizations Devotion to Ecology, Health, Safety, and the Environment
10. A product for the detection and characterization of brucellosis launched at University of Navarra
11. Mens Health Guide for Ages 40 - 60 Launched by NHS Choices

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
OptumHealth Launched myOptumHealth.com, Health and Wellness Information Destination with Clinically Reviewed Content, Tools and Resources
OptumHealth Launched myOptumHealth.com, Health and Wellness Information Destination with Clinically Reviewed Content, Tools and Resources
(Date:12/2/2009)... Award-winning author James A. Feinst...ook, Short White Coat: Lessons from Patients on Be... the third year of medical school--the grueling cl...IA, PA (PRWEB) December 2, 2009 -- Most people wi...es dressed in a tiny hospital gown or staring at s...
(Date:12/2/2009)... SAN DIEGO, Dec. 2 Gen-P... the 21st Annual Piper Jaffray Health Care Confere...ion is scheduled to be webcast live and may be acc...en-Probe,s website at www.gen-probe.com . The web...vent. ,, About Gen-Probe ,, Gen-Probe Inc...
(Date:12/2/2009)... JOHANNESBURG, Dec. 2 LeapFrog Inv... million) investment in AllLife, the innovative So... and diabetes. The investment brings together Leap...and AllLife, one of Africa,s most innovative insur... World AIDS Day. ,, "AllLife has developed a di...
(Date:12/2/2009)...esults of a large-scale clinical trial presented t...iety of North America (RSNA) provide the first str...trasound for women with dense breasts who are at e...tudy confirmed that MRI is highly sensitive in dep...ual screening with ultrasound in addition to mammo...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Reportlinke...is available in its catalogue: ,, The Future o...arket Forecasts to 2015, Competitive Benchmarking,...//www.reportlinker.com/p0166814/The-Future-of-Cent...Forecasts-to-2015-Competitive-Benchmarking-Product...
Breaking Medicine News(10 mins):Health News:Beneath the Short White Coat: A Medical Student Reveals All 2Health News:Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today 2Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 2Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 3Health News:Annual screening with breast ultrasound or MRI could benefit some women 2Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 15Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 16Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 17Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 18Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 19Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 20Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 21Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 22
...://www.EvasVillage.org ), a comprehensive New Jers...se in need in 2009, and a decline in foundation gr...on, New Jersey, seeks additional funding to meet t...grams and a decline in foundation grants and gift...
...portunities for improvement amidst high satisfacti...ocus) May 27, 2009 -- Nursing home consumer satisf...hile workforce satisfaction is at its highest leve...nt research firm My InnerView shows a majority (...
... sector can play a leadership role in reducing the...educing its climate footprint. These efforts, som...e the serious health threats posed by global warmi... Without Harm. , , "By reducing its climate footp...
...ked together to develop a computer model to help a...influenza. The tool can help estimate false negati...reening process, and so assess the risk of infecte...hland, Washington, and teams at Oak Ridge National...
...Central Valley , , MOUNTAIN VIEW, Calif., May 26 ...nd leading providers of kidney dialysis services a...nnounced their participation at the National Kidne... Satellite Healthcare,s commitment to kidney healt...
...for four hours before they allowed him to enter th...ingerprints to disappear. His oncologist is now ad...ith the commonly used drug, capecitabine, to carry... [1], published online today (Wednesday 27 May). A...
Other Medicine News:Health News:Eva's Village, a Comprehensive New Jersey Anti-Poverty charity, Seeks Additional Funding to Meet the Increasing Need Along with a Decline in Donations 2Health News:Eva's Village, a Comprehensive New Jersey Anti-Poverty charity, Seeks Additional Funding to Meet the Increasing Need Along with a Decline in Donations 3Health News:Eva's Village, a Comprehensive New Jersey Anti-Poverty charity, Seeks Additional Funding to Meet the Increasing Need Along with a Decline in Donations 4Health News:Eva's Village, a Comprehensive New Jersey Anti-Poverty charity, Seeks Additional Funding to Meet the Increasing Need Along with a Decline in Donations 5Health News:Nursing Home Consumer, Workforce Satisfaction Reaches New Highs 2Health News:World Health Organization Says Health Sector Can Lead the Fight Against Climate Change 2Health News:Pandemic passenger screening 2Health News:Satellite Healthcare Walks for Kidney Health 2Health News:Cancer drug causes patient to lose fingerprints and be detained by US immigration 2
(Date:12/1/2009).... 1 Former New Jersey As...ed when his radiotherapy treatment sessions for pr...to less than five. Midway through his course of t...Cancer Center acquired the region,s first Rapid...ical Systems (NYSE: VAR ), making it possible fo...
(Date:12/1/2009)... 1 The educational resou...mproving Life," created by Lilly USA (NYSE: LLY ...om/value_of_medicine.jsp . The booklet supports Li..." and encourages an open dialogue with patients, p...al industry practices. ,, "Today, Lilly and ot...
(Date:12/1/2009)...tCall/ -- WebMD Health Corp. (Nasdaq: WBMD ), the...nced the honorees of the 2009 WebMD Health Heroes ...r Americans with extraordinary stories of personal...elp others achieve better health. ,, (Photo...Y18114 ) ,, "WebMD is honoring its 2009 Health...
Breaking Medicine Technology:Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 3Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 4Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 5Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 2Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 3Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 4WebMD Announces 2009 Health Heroes 2WebMD Announces 2009 Health Heroes 31 scan per patient is not always enough 59758 11 scan per patient is not always enough 59758 2Catching a killer one spore at a time 10417 1Catching a killer one spore at a time 10417 2PETAs push for changes in USDA testing pays off for animals 10415 1
...iles Additional Data to the NEBIDO NDA ...XINGTON, Mass., Jan. 22 Indevus,Pharmaceuticals, ...ositive,results from its Phase III program for NEB...ctable testosterone therapy under development for ... announced today has been,filed with the U.S. Food...
... Trial to Evaluate Anti-Tumor Activity of Bavituxi...nd Paclitaxel-, TUSTIN, Calif., Jan. 22 Peregrin...al stage biopharmaceutical,company developing mono...hepatitis C virus (HCV) infection, today announced...tuximab in combination with chemotherapy in,patien...
Other Medicine Technology:Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R) 2Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R) 3Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R) 4Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R) 5Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R) 6Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 2Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 3Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 4
...tural anatomy of the eyelid for maximum patient co...nstrument for ease of insertion. Easily removal wi...fer a slightly smaller bulb for easier insertion. ...shed silicone as the plugs with slanted collarette...
Crawford Hook
Mini MONOKA
...hread-guide reducing time and trauma in lacrimal d...ed into the nasolacrimal duct and a thin prolene t...ithdrawn leaving the polypropylene thread to pull ...thin Polyvinylpyrrolidone (PVP) coating that makes...
Medicine Products: